Submit

Amwill Healthcare Limited IPO

Amwill Healthcare Limited

Issue Open

Feb 05, 2025

Price Band

₹ 105 to ₹ 111 per share

Issue Size

59.98 Cr

Credit of Shares to Demat

Feb 11, 2025

Issue Close

Feb 07, 2025

Bid Lot

Listing Exchange

BSE SME

Cut off time for UPI Mandate Confirmation

Feb 07, 2025 05:00 PM

Issue Type

Book build offer

Minimum Order Quantity

Allotment Details

Feb 10, 2025

Face Value

Rs 10/- per share

Listing On

Feb 12, 2025

Refunds

Feb 11, 2025

About the company:

Amwill Healthcare Limited is a derma-cosmetic development company that focuses on dermatological, cosmeceutical, and aesthetic products. By collaborating with contract manufacturers, distributors, and third-party developers, the company can concentrate on formulation and innovation while outsourcing manufacturing, packaging, and distribution.

Amwill Healthcare, which operates in Karnataka, Andhra Pradesh, and Telangana, strategically deepens its presence before entering new markets. The company creates both generic dermatological solutions and specialized treatments for diseases such as acne, fungal infections, and vitiligo.

Founded by Managing Director Anand Gandhi, the company was acquired from M/s. Amwill Healthcare via an asset transfer agreement. It ensures targeted product development by leveraging dermatologists' insights. Amwill Healthcare provides high-quality, compliant derma-cosmetic solutions through its extensive network of certified manufacturers and third-party developers.

FAQ’s

Can I trade an IPO through a Discount Broker?

What are the benefit of buying & selling IPOs through a discount broker?

How is it possible to trade an IPO through a discount broker when SEBI has made mandatory to buy an IPO through ASBA?

How can I buy and sell IPO through a discount broker?

What documents are required to open an account with Samco?